RESILIENT Part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer Journal Article
| Authors: | Spigel, D. R.; Dowlati, A.; Chen, Y.; Navarro, A.; Yang, J. C. H.; Stojanovic, G.; Jove, M.; Rich, P.; Andric, Z. G.; Wu, Y. L.; Rudin, C. M.; Chen, H.; Zhang, L.; Yeung, S.; Benzaghou, F.; Paz-Ares, L.; Bunn, P. A.; on behalf of the RESILIENT Trial Investigators |
| Article Title: | RESILIENT Part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 19 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-07-01 |
| Start Page: | 2317 |
| End Page: | 2326 |
| Language: | English |
| DOI: | 10.1200/jco.23.02110 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PMCID: | PMC11210946 |
| PUBMED: | 38648575 |
| DOI/URL: | |
| Notes: | Accession Number: 178087381 -- Entry Date: In Process -- Revision Date: 20240628 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: CINAHL Plus with Full Text |
